ABI-RACE: A Phase II Open Label, Parallel group study of Abiraterone Acetate in African American and Caucasian Men with Metastic Castrate Resistant Prostate Cancer
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Janssen Pharmaceutica, Inc.
Start Date
June 1, 2013
End Date
May 31, 2021
Administered By
Duke Cancer Institute
Awarded By
Janssen Pharmaceutica, Inc.
Start Date
June 1, 2013
End Date
May 31, 2021